The Board of Directors and staff of National Disease Research Interchange (NDRI) celebrate the extraordinary life and unparalleled legacy of
D. Walter Cohen, DDS, who died on June 29, 2018 in Philadelphia.
The 2018 Warren Alpert Foundation Prize has been awarded to five scientists for transformative discoveries in the fields of genetics, physiology, pulmonology and pharmacology that have led to the development of life-altering precision-targeted treatments for the devastating multiorgan disease cystic fibrosis (CF).
Read NDRI's 2018 Research Nexus for a recap of our Service to Science Awards Dinner, an exciting update on programs and initiatives, and learn how NDRI investigators are accelerating scientific discoveries!
TaiRX Announces License Agreement with Northwestern University and Ann & Robert H. Lurie Children's Hospital of Chicago for Invention led by Dr. Mary Hendrix.
NDRI is pleased to share announcement of some exciting findings from the Dr. Meenhard Herlyn’s lab at The Wistar Institute. Dr. Herlyn is a Chair Emeritus of NDRI Board of Directors. Congratulations to you and your colleagues!
Congrats to Dr. Lou Phillipson on being named a 2018 recipient of the Order of Lincoln by Illinois Governor, Bruce Rauner. The Order of Lincoln is the state’s highest honor for professional achievement and public service.
Join NDRI's President & CEO, BIll Leinweber and Senior Vice President, Strategic Intiatives for the Pennsylvania Business Mission to israel. NDRI leadership is looking forward to connecting with the incredible Life Science Community.
Monday, July 17th NDRI President & CEO, Bill Leinweber and Dr. Gene Kopen, Senior Vice President, Strategic Initiatives met with staff of the National Institute of Environmental Health Sciences (NIEHS) for an engaging seminar entitled, “The Critical Role of Human Tissue Environmental Health Sciences Research”.
Mary J.C. Hendrix, PhD, Chair of the NDRI Board and President of Shepherd University shared that, “Shawn Blackburn’s expertise in technology to support research, Dr. Dib-Hajj’s research accomplishments and experience utilizing human tissue for research and Megan Singleton’s knowledge and experience in law, bioethics and human subject protections will be invaluable to advancing the mission of NDRI.”
NDRI has the privilege of serving as a partner to scientists across the world dedicated to advancing understanding of disease and the discovery of treatments and cures. The scientists we serve – our research partners – toil for answers built on evidence devoid of contamination of any kind.
Disease and disability have no political affiliation. The suffering endured by patients and the pain and heart break shared by their loved ones is experienced no differently by Democrats, Republicans or Independents.
NDRI proudly supports the March for Science activities that will take place in locations across our nation and the world on Saturday, April 22, 2017. We encourage all individuals who have a vested interest in a life free of disease and disability to make certain that those involved in scientific policy development and research funding decisions understand that our future depends on science.
The National Disease Research Interchange (NDRI) is the nation’s leading source of human tissues, cells and organs for scientific research. As a not-for-profit 501 (c)(3) organization founded in 1980, NDRI's mission is to provide human biospecimens to advance biomedical/bioscience research and development worldwide. NDRI is funded in part by the National Institutes of Health, public and private foundations and organizations, pharmaceutical and biotechnology corporations.
For more information on how NDRI can support your biomedical research visit: http://ndriresource.org/for-researchers.
The nationwide March for Science movement has five overarching goals: humanize science, support the scientific process and scientists, advocate for accessible and inclusive science, partner with the public, and enable the use of science to improve society. Each of these values speaks to Philadelphia’s own scientific community and highlights some unique challenges that our region faces.
The National Disease Research Interchange (NDRI) has been awarded a research subcontract of $225,453 to support the National Institute of Allergy and Infectious Diseases (NIAID) Division of Clinical Research (DCR) HIV Replication Study aimed at improving HIV treatment.